Bloomberg Law Webinar: Interpreting Myriad: Gene Patenting and Other Inventions at Risk

Bloomberg Law Webinar: Interpreting Myriad: Gene Patenting and Other Inventions at Risk

Speaking Engagement

The webinar will provide an assessment of the June 13, 2013 Supreme Court opinion in Association for Molecular Pathology v. Myriad Genetics Inc. The court considered a fundamental question: Are human genes patentable? But the patent community had a broader concern-the high court's recent statements that seem to question patent eligibility on a number of other fronts. Did the justices limit their review or did they deal a significant blow to a broad swath of patents?

WilmerHale Partner Thomas Saunders will serve on a panel to review the legal arguments and gauge the potential impact on biotechnology and other markets.

Read More About the Event

Speakers